May et al., 2000 - Google Patents
Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathyMay et al., 2000
View HTML- Document ID
- 508985449293896569
- Author
- May E
- Märker–Hermann E
- Wittig B
- Zeitz M
- Zum Büschenfelde K
- Duchmann R
- Publication year
- Publication venue
- Gastroenterology
External Links
Snippet
Intestinal T lymphocytes activated by antigen are suspected to play a key role in enterogenic spondyloarthropathies (SpA). Therefore, we aimed to identify and functionally characterize T- cell clones that are coexpanded in the intestinal mucosa and the synovium. Colon …
- 210000001744 T-Lymphocytes 0 title abstract description 143
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Similar Documents
Publication | Publication Date | Title |
---|---|---|
May et al. | Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy | |
Krensky et al. | Specificity of OKT4+ cytotoxic T lymphocyte clones. | |
Parel et al. | Presence of CD4+ CD8+ double‐positive T cells with very high interleukin‐4 production potential in lesional skin of patients with systemic sclerosis | |
Cong et al. | Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12 | |
Kassiotis et al. | Impairment of immunological memory in the absence of MHC despite survival of memory T cells | |
Lundqvist et al. | Intra-epithelial lymphocytes. Evidence for regional specialization and extrathymic T cell maturation in the human gut epithelium | |
Manavalan et al. | Alloantigen specific CD8+ CD28− FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity | |
Arlettaz et al. | Activating CD94: NKG2C and inhibitory CD94: NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR αβ lymphocytes | |
Wu et al. | Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease | |
Norris et al. | Lymphocyte activation in the pathogenesis of psoriasis | |
Camus et al. | Oligoclonal expansions of mucosal T cells in Crohn's disease predominate in NKG2D-expressing CD4 T cells | |
JPH04506512A (en) | Vaccination and methods against diseases caused by pathogenic responses of specific T cell populations | |
Hohlfeld et al. | Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis. | |
Latham et al. | Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints | |
JPH10504181A (en) | Conserved T cell receptor sequence | |
Sedgwick et al. | Antigen-specific damage to brain vascular endothelial cells mediated by encephalitogenic and nonencephalitogenic CD4+ T cell lines in vitro. | |
Leibelt et al. | Dedicated immunosensing of the mouse intestinal epithelium facilitated by a pair of genetically coupled lectin-like receptors | |
Vadstrup et al. | NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8+ T cell migration | |
Li et al. | Expanded tumor-reactive CD4+ T-cell responses to human cancers induced by secondary anti-CD3/anti-CD28 activation | |
Aissaoui et al. | Prevention of autoimmune attack by targeting specific T‐cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis | |
Li et al. | Mycobacteria and human heat shock protein—specific cytotoxic t lymphocytes in rheumatoid synovial inflammation | |
Williams et al. | T cell repertoire homogeneity and blood-gut overlap in patients with inflammatory bowel disease | |
Lafarge et al. | Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of γδ T cells | |
Märker-Hermann et al. | Pathogenesis of human leukocyte antigen B27–positive arthritis: information from clinical materials | |
Ordóñez et al. | Cell‐Mediated Cytotoxicity in Lyme Arthritis |